Paul Bradley joins SCM Pharma as Operations Director

Will head all operational activities including production, warehouse and facilities

UK-based contract development and manufacturing organisation (CDMO) SCM Pharma has strengthened its senior management team by recruiting a new Operations Director.

Paul Bradley joins the specialist manufacturer from Hospira Aseptic Services. He takes responsibility for all operational activities at SCM Pharma including production, warehouse and facilities.

With more than 15 years’ experience of research, development and manufacturing, Bradley moved into the sterile manufacturing area in 2007. With a BSc (Hons) in Chemistry from Durham University and a Management Diploma from Loughborough College, he will play a pivotal role in developing robust and efficient processes and systems at SCM Pharma on technically challenging products.

SCM Pharma specialises in the sterile manufacture of products for clinical trials along with the supply of licensed drugs in niche markets.

You may also like

Manufacturing

Shire buys assets of SCM Pharma

Confirms that 80 jobs are safeguarded at Northumberland-based company
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

HAPI capacity reaches an all-time high

While today’s drugs are more targeted and effective, they bring with them production issues of sterility and higher potency. Susan Birks reports on how the contract manufacturing market has responded to the growing demand for specialist high potency and sterile services
You need to be a subscriber to read this article.
Click here to find out more.
Containment

Handle with care – high potency APIs

Contract manufacturer SCM Pharma, which handles small volume runs of cytotoxic powders and liquids for several clients, outlines the basic containment and cleaning requirements for ensuring worker safety and product purity
Manufacturing

SCM\'s Prudhoe facility gains FDA approval

UK CDMO supports BTG for commercial launch of varicose veins treatment
Manufacturing

SCM Pharma gains MHRA approval for commercial facility

The site will be used for the supply of licensed commercial products and to complement its clinical manufacturing facility
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

The changing landscape of clinical trial manufacturing

With regulation changes, the death of the blockbuster, focus on personalised medicines and less R&D spend than ever before, the clinical trial manufacturing landscape has undergone many changes. SCM Pharma’s Dianne Sharp reviews the sector and outlines what companies of the future could look like
Manufacturing

SCM supports BTG in Varisolve scale-up

CDMO has previously been providing clinical development consultancy for varicose vein treatment
Subscribe now